Optimal multistage designs for randomised clinical trials with continuous outcomes
Multistage designs allow considerable reductions in the expected sample size of a trial. When stopping for futility or efficacy is allowed at each stage, the expected sample size under different possible true treatment effects (δ) is of interest. The δ-minimax design is the one for which the maximum...
Main Authors: | , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Blackwell Publishing Ltd
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499690/ |